IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2006;47:5181-5190.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0556
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samardzija, M.
Right arrow Articles by Grimm, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samardzija, M.
Right arrow Articles by Grimm, C.

Caspase-1 Ablation Protects Photoreceptors in a Model of Autosomal Dominant Retinitis Pigmentosa

Marijana Samardzija, Andreas Wenzel, Markus Thiersch, Rico Frigg, Charlotte Remé, and Christian Grimm

From the Laboratory for Retinal Cell Biology, Department of Ophthalmology, the Center for Integrative Human Physiology (CIHP), and the Neuroscience Center Zürich (ZNZ), University of Zürich, Zürich, Switzerland.


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
PURPOSE. Caspase-1 gene expression has been reported to be upregulated during light-induced retinal degeneration and to be reduced after neuroprotective treatments. Thus, caspase-1 may be proapoptotic in the retina. To test directly the role of caspase-1 in photoreceptor apoptosis, three mouse models were analyzed for retinal degeneration in the presence or absence of caspase-1.

METHODS. Photoreceptor apoptosis was monitored in one model of induced (exposure to light) and in two models of inherited (rd1, VPP) retinal degeneration. Retinal degeneration was assessed qualitatively by light microscopy and quantitatively by the determination of free nucleosomes with ELISA or by rhodopsin measurements. Gene expression and protein levels were assessed by real-time RT-PCR and by Western blot analysis, respectively.

RESULTS. Levels of caspase-1 proenzyme increased in all models of retinal degeneration concomitantly with the onset of cell death. Maturation or classic activity of caspase-1 was not detected in the retina. Ablation of caspase-1 was protective in the model of adRP (VPP mouse), but not in the two other models. Ablation of interleukin-1 receptor type 1 was without effect. Expression of monocyte chemoattractant protein (MCP)-1 increased in the model protected by caspase-1 ablation.

CONCLUSIONS. Increased retinal expression of caspase-1 proenzyme may be a common marker for photoreceptor degeneration. The differential effects of caspase-1 ablation suggests a modulatory role of caspase-1 for photoreceptor apoptosis in some but not all models. Such a modulatory activity may involve a caspase-1 function different from the classic activation of interleukin-1ß.

Photoreceptor cell death is a hallmark of most retinal dystrophies. Dying photoreceptors share all the major morphologic features of apoptosis including nuclear condensation and nucleosomal DNA fragmentation, cytosolic condensation, and cell shrinkage as well as the formation of apoptotic bodies. Apoptosis has been considered as the final common pathway of cell death in retinal degenerations.1 2 3 The intracellular signals that lead to apoptosis of the visual cells are still far from conclusive. The caspases, a family of cysteine proteases, have been implicated in the regulation of apoptotic cell death in a variety of systems. Caspase-dependent cell death is regulated via one of three major pathways: the receptor- or the mitochondria-mediated cell signaling pathway or by an endoplasmic reticulum stress response. One of the key events triggering caspase-dependent apoptosis is the activation of initiator caspases by oligomerization of the inactive cellular precursors in response to death stimuli. Once activated, initiator caspases induce a tightly regulated cascade of events propagating the death signal by activation of downstream effector caspases leading to cleavage of various cellular substrates in a process that culminates in cell death (reviewed in Ref. 4 ).

In experimental models developed to study cell death in the retina, several different caspases—in particular, caspase-3—have been reported to be activated during apoptosis. These models include cell death induced by ischemia,5 excitotoxicity,6 treatment with autoantibodies,7 and lead and calcium overload.8 Caspase activation has also been demonstrated in some animal models of inherited retinal degeneration such as rhodopsin S334ter rats,9 Royal College of Surgeon (RCS) rats,10 tubby mice,11 and rds mice.12 For retinal degeneration in the rd1 mouse, which carries a mutation in the gene encoding the phosphodiesterase ß-subunit (PDE6ß)13 contradictory data regarding the involvement of caspase-3 have been reported. Both caspase-dependent14 15 16 17 and -independent18 photoreceptor cell death have been described.

Caspase (Casp)-1 has been identified as the mammalian homologue to the nematode ced-3 gene19 and has been implicated in programmed cell death. Today, Casp-1 is mainly associated with inflammation, for its ability to cleave the inactive 31-kDa cytokine pro-interleukin-1-ß (pro-IL-1ß) into an active 17-kDa mature form.20 21 However, evidence of an involvement of Casp-1 also in apoptosis has been demonstrated in several in vitro and in vivo systems.22 23 24 25 Using the model of light-induced retinal degeneration, we and others have shown that Casp-1 gene expression is increased in retinas injured by exposure to light26 27 28 and that treatments that increase the resistance against light-induced damage (e.g., hypoxic preconditioning) prevent increased Casp-1 expression.29 These findings suggest that Casp-1 is involved in the mediation or regulation of photoreceptor apoptosis after a light-induced insult.

In the present study, we tested whether Casp-1 was induced in other models of retinal degeneration as well and whether ablation of Casp-1 would influence the degenerative process. For this purpose, we used the rd1 mouse as a model for autosomal recessive retinitis pigmentosa (arRP) and the VPP mouse, representing a model for autosomal dominant RP (adRP). The rd1 mouse develops a fast and light-independent degeneration of photoreceptors starting around postnatal day (PND)10.13 The VPP mouse expresses a mutant rhodopsin transgene encoding a protein with three amino acid substitutions (V20G, P23H, and P27L)30 one of which (P23H) represents the most common cause for adRP in the United States. The expression of the transgene leads to photoreceptor death with loss of function.30 31 Retinal degeneration in the VPP mouse is accelerated by light32 33 but proceeds slower than in the rd1 mouse. We analyzed the course of retinal degeneration in the light-induced and the two inherited models in the presence and absence of functional Casp-1 and showed that the lack of Casp-1 activity affected the retina differentially in the three models.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
Animals
All procedures concerning animals were in accordance with the regulations of the Veterinary Authority of Zurich and with the ARVO Statement for the use of Animals in Ophthalmic and Vision Research. All animals were raised in cyclic light (12:12 hours; 60 lux at cage level).

BALB/c mice were purchased from Harlan (Horst, The Netherlands). Casp-1-deficient mice (Casp1–/–) are described elsewhere34 and were generously provided by Winnie Wong (BASF Bioresearch, Worcester, MA). VPP mice (generously provided by Muna Naash, University of Oklahoma, Oklahoma City, OK) and wild-type mice (both on a 129.B6 background) and rd1 mice (C3H/HeJ) were maintained at the University Hospital Zurich. The IL-1R1–/– mice, backcrossed onto BALB/c background for more than eight generations,35 36 were kindly provided by Manfred Kopf (ETH, Zurich, CH). The double mutants rd1/Casp1–/–, VPP/Casp1–/–, and VPP/IL-1R1–/– were generated by classic breeding schemes. Genotyping was performed by PCR on genomic DNA, using the primers shown in Table 1 . For rd1 genotyping, PCR products were digested with DdeI, as described elsewhere.37 All mouse strains were homozygous for the Rpe65450Leu variant.38


View this table:
[in this window]
[in a new window]

  		TABLE 1. Primer Sequences

 
Exposure to Light and Assessment of Retinal Damage
Light damage was induced in dark-adapted 6- to 8-week-old mice placed in cages with reflective interior by exposure to 5 klux/1 hour (albino strains) or to 13 klux/2 hours (pigmented, with dilated pupils) of diffuse white fluorescent light, as described elsewhere.39 The extent of light-induced damage in the retinas after different recovery periods in darkness was quantified by the ELISA-based determination of free nucleosomes in the cytoplasm (generated after internucleosomal cleavage of genomic DNA during the course of apoptosis), with a cell viability kit (Cell Death Detection Kit no. 1920685; Roche Diagnostics, Basel, Switzerland) according to the manufacturer’s recommendation or by the determination of the rhodopsin content after 16 hours of dark adaptation as described.40

Qualitative assessment of retinal tissue was performed by light microscopic viewing of sections from the lower temporal retina of 2.5% glutaraldehyde-fixed and Epon 812-embedded eyes, as has been described.39

Semiquantitative RT-PCR Analysis
RNA isolation from retinas and cDNA synthesis were performed as described previously.26 Primer pairs used for specific amplifications were designed to span intronic sequences or cover exon-intron boundaries (Table 1) . Gene expression was analyzed by real-time RT-PCR with a polymerase ready mix (SYBR Green JumpStart Taq ReadyMix; Sigma-Aldrich, Munich, Germany) and a thermocycler (LightCycler; Roche Diagnostics). Amplification specificity was controlled by performing a melting curve analysis of the amplified PCR fragments and by visualizing amplified products on agarose gels. For relative quantification of gene expression, mRNA levels were normalized to ß-actin using the {Delta}{Delta}CT (comparative threshold cycle) method and relative values were calculated with a respective control sample used for calibration, as indicated in the Results section. Each reaction was run in triplicate.

Western Blot Analysis
Retinas were homogenized in 100 mM Tris/HCl (pH 8.0) and analyzed for protein content by using the Bradford method. Standard SDS-PAGE and Western blot analysis were performed. Polyclonal rabbit anti-casp-1, -3, -6, -7, (kindly provided by Peter Vandenabeele, Ghent University, Belgium), anti-casp-1 (p10) (sc-514; Santa Cruz Biotechnology, Santa Cruz, CA), anti-casp-9 (no. 9504; Cell Signaling, Danvers, MA) and sheep anti-IL1ß (S329/B4b, kind gift from Stephen Poole; NIBSC [Institute for Biological Standards and Control], Potters Bar, UK) antibodies were applied, followed by a horseradish peroxidase (HRP)-conjugated secondary anti-rabbit (no. NA934; GE Healthcare, Munich, Germany) or anti-sheep/goat (STAR88P; Serotec, Oxford, UK) antibody. To control for equal protein loading, membranes were reprobed with goat anti-actin antibody (sc-1616; Santa Cruz Biotechnology). Immunoreactivity was visualized using a Western blot detection kit (Renaissance; PerkinElmer Life Sciences, Emeryville, CA).

Determination of WEHD-pNA Cleavage
Retinas were dissected and homogenized in 120 µL of cold lysis buffer (BF14100; R&D Systems, Minneapolis, MN) followed by incubation on ice for 30 minutes. The retinal homogenates were centrifuged at 15,000g for 10 minutes at 4°C. The protein content of supernates was determined by a protein assay (Bio-Rad, Hercules, CA) using bovine serum albumin as the standard. An equal quantity (150 µg) of retinal protein was loaded into each well of a microtiter plate. Lysates were incubated with an equal volume of 1x reaction buffer and Casp-1 substrate, according to the manufacturer’s instructions at 37°C for 18 hours. Cleavage of the peptide substrate WEHD-pNA was monitored by liberation of the chromogenic pNA measuring absorption at 405 nm. Three animals were analyzed per condition.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
To establish the time course of light-induced photoreceptor apoptosis, we used two different methods. To quantify the amount of cells, which irreversibly entered the process of apoptotic cell death, that is cells in the phase of internucleosomal DNA cleavage, we measured the release of free nucleosomes in retinal cell lysates by ELISA. To assess cell loss and morphologic changes by apoptosis in the retina, we used classic histologic methods.

Nucleosomal release above background was detectable at 6 hours after illumination and peaked at 36 hours after exposure to light (Fig. 1A) as described earlier.41 Signal intensity declined slowly thereafter, but relatively high levels remained up to 3 days after illumination (the last time point tested). Morphologic changes in light-exposed retinas were detectable by light microscopy at 1 day after exposure (Fig. 1B) . Rod outer segments (ROS) and rod inner segments (RIS) were severely disturbed, and many photoreceptor nuclei in the outer nuclear layer (ONL) showed condensed chromatin. At 2 days after illumination, the ONL was thinned and contained predominantly nuclei with condensed chromatin. The area of ROS and RIS showed complete devastation. The gap between ONL and pigment epithelium (PE) at days 2 and 5 may be preparation artifacts resulting from the weakened retinal structures. Between 2 and 5 days after exposure, most photoreceptor nuclei were lost. Between 5 and 10 days, debris of dead cells was removed, and no further change was obvious up to day 30 after the exposure.


Figure 1
View larger version (81K):
[in this window]
[in a new window]

  		FIGURE 1. Retinal apoptosis and expression of caspases after exposure to light. Dark-adapted BALB/c (A, C, D) or 129.B6 (B) mice were not exposed (dark) or were exposed to 5 klux of white fluorescent light for 1 hour (A, C, D) or to 13 klux for 2 hours (B). Retinas were harvested immediately (I) or at different time points as indicated. (A) Cell death in the retina was detected by ELISA-based measurement of free nucleosomes in cytoplasmic extracts. Release of nucleosomes was detected as early as 6 hours after exposure and peaked at 36 hours. Data points represent the OD405 of retinas of individual mice. Note the logarithmic scale on the y-axis. (B) Retinal morphology of 129.B6 mice at the indicated time points before (dark) or after exposure to light. (C) Apoptotic cell death was associated with accumulation of the Casp-1 proform. Western blots show proforms of individual caspases at different time points after exposure to light as indicated. Levels of Casp-1 increased steadily, whereas expression of other tested caspases remained constant. Representative Western blot analyses from at least three independent experiments are shown. Membranes were reprobed with ß-actin to control for equal protein load. (D) Long-term follow-up of Casp-1 expression after exposure to light. Expression of Casp-1 peaked at 5 days after illumination before basal levels were reached after 20 days. ß-Actin was tested as loading control.

 
DNA cleavage, as detected by the cell death detection ELISA assay, precedes the removal of the affected cell. Its peak was detected between 1 and 3 days after the insult, whereas physical loss of cells followed after a delay of approximately 1 day (peak between 2 and 5 days). Accordingly, we focused on the first 3 days after exposure to light for the analysis of biochemical events in the signaling cascades leading to cell death.

Expression and Activity of Caspase-1 in Retinal Degeneration
In many systems, apoptotic cell death is mediated by caspases. In the light-induced damage system, however, Western blot analysis revealed that the amount of the proenzymatic forms of caspase-3, -6, -7, and -9 remained unchanged over a period of 3 days after the exposure to light (Fig. 1C) . In addition, cleaved (activated) fragments of these caspases remained undetectable. Together with results from others,18 42 this suggests that light-induced damage is independent of these caspases. In contrast, increasing Casp-1 proenzyme levels were detected after light treatment (Fig 1C) . Induction of Casp-1 followed the initial time course of nucleosomal release (Fig. 1A) starting at 6 hours after illumination. In contrast to the release of nucleosomes, Casp-1 proenzyme increased continuously, reaching a maximum at 5 days. Thereafter, pro-Casp-1 levels declined to baseline (Figs. 1C 1D) . Thus, elevated Casp-1 levels were present beyond the peak of apoptosis.

The major known role of active Casp-1 is proteolytic processing of IL-1ß from a 33-kDa precursor protein to the 17-kDa mature form. Light exposure induced expression of IL-1ß, with peak mRNA levels at 12 hours (Fig. 2A) and maximum protein (proform) levels at 24 to 72 hours after illumination (Fig. 2B) . Although both Casp-1 protease and IL-1ß substrate were induced and present in high amounts at 72 hours after illumination, we did not observe mature IL-1ß by Western blot analysis (Fig. 2B) or ELISA (not shown). Using an in vitro assay for WEHD-pNA substrate cleavage, we also did not detect increased Casp-1 activity in retinal extracts after exposure to light (Fig. 2C) . Because Casp-1 has to be cleaved to become active, we tested for the presence of the mature form of Casp-1 in retinal extracts prepared 72 hours after illumination. Using two different antibodies that recognized cleaved Casp-1 products in control experiments (p20 and p10, respectively), we did not detect any cleaved products of Casp-1 in retinal extracts (Fig. 2D) . The lack of IL-1ß substrate cleavage and of the cleaved Casp-1 mature form suggests that Casp-1 did not mature and was therefore not activated, despite the increased expression of the proform.


Figure 2
View larger version (39K):
[in this window]
[in a new window]

  		FIGURE 2. Caspase-1 activity was not detected after exposure to light. Dark-adapted BALB/c mice were not exposed (dark) or were exposed for 1 hour to 5 klux, and retinas were harvested immediately (I) or at different time points thereafter as indicated. (A) Levels of IL-1ß mRNA increased after exposure and peaked at 12 hours after illumination. Relative mRNA levels were assessed by exponential RT-PCR (mean ± SD of three reactions performed on a pool of RNAs from three retinas isolated from three different animals per time point). (B) Il-1ß was not processed after light-induced damage. Increasing pro-IL-1ß levels were detected by Western blot analysis with increasing time (as indicated) after exposure to light (top). Mouse recombinant mature IL-1ß (17 kDa) was used as a positive control (pos) for immunoblot analysis. Mature IL-1ß was not detected in retinal extracts. *31 kDa proform of Il-1ß, **unspecific signal, ***mature form of Il-1ß. ß-Actin served as the loading control (bottom). (C) Casp-1 was not enzymatically active after light-induced damage. WEHD-pNA cleavage was determined spetrophotometrically in vitro using an ELISA-based method on retinal extracts prepared from control (dark) or from retinas isolated at different time points after exposure to light, as indicated. pos: recombinant active Casp-1 as the positive control (the mean ± SD of three retinas from three different animals). (D) Pro-Casp-1 was not processed after exposure to light. Retinal extracts prepared at 72 hours after exposure to light were tested with two antibodies recognizing the Casp-1 proform and p20 active form (left) or the Casp-1 proform and the p10 active form (right). Extract of Casp-1 knockout mice (KO) was loaded for specificity control, and ß-actin served as the loading control (bottom). pos: recombinant active Casp-1 as positive control for antibodies.

 
To test whether increased Casp-1 levels is be a general phenomenon of retinal degeneration, we also analyzed its expression in two models of inherited retinal degeneration. The rd1 mouse is characterized by fast photoreceptor degeneration, beginning at approximately postnatal day 10 (PND10) and peaking at ~PND13,43 whereas retinal degeneration in the transgenic VPP mouse30 31 has a later onset, and degeneration proceeds more slowly44 (compare the images in Figs. 5A and 5B ). Although retinal degeneration in the rd1 mouse may14 15 16 17 or may not18 involve Casp-3, the molecular pathways of photoreceptor apoptosis in the VPP mouse have not been investigated so far. Whereas wild-type animals expressed low amounts of Casp-1 protein that remained unchanged at all time-points, increased levels of Casp-1 were found early after onset of degeneration in rd1 and VPP retinas (Figs. 3A 3B) . In both models of inherited retinal degeneration, Casp-1 levels increased further with age. Of note, Casp-1 levels in the rd1 retina where highest at PND37, at a time point when loss of photoreceptors was nearly complete (see Fig. 5A ). This suggests that Casp-1 was expressed in cells different from photoreceptors.


Figure 3
View larger version (24K):
[in this window]
[in a new window]

  		FIGURE 3. Induction of Casp-1 expression in inherited models of retinal degeneration. rd1 (A) and VPP (B) mice were raised in dim cyclic light, and retinas were harvested on different postnatal days, as indicated. Each time point was compared with age-matched wild-type mice. Casp-1 expression was tested in total retinal homogenates by Western blot analysis. Extracts from Casp1–/– mice served as the control for antibody specificity. Casp-1 activation was monitored by the WEHD-pNA substrate cleavage assay as in Fig. 2C . (A) Casp-1 levels increased in retinas of rd1 mice starting at ~PND14. (B) Casp-1 levels increased in retinas of VPP mice starting at ~PND21. Mature Casp-1 was not detected at any age in any genotype tested (not shown). (C) No classic Casp-1 activity was detected in extracts from retinas of VPP mice. WEHD-pNA cleavage was measured spectrophotometrically in retinal extracts from 4-week-old VPP mice and corresponding wild-type control animals. pos: activity of recombinant active Casp-1 as positive control. The mean ± SD of three independent retinas from three different animals.

 

Figure 4
View larger version (63K):
[in this window]
[in a new window]

  		FIGURE 4. Ablation of Casp-1 did not protect retinal morphology against light-induced damage. Dark-adapted, pigmented (wild-type, Casp1–/–), and albino (BALB/c, IL-1R1–/–) mice were exposed for 2 hours to13 klux or for 1 hour to 5 klux of light, respectively. Retinal morphology of mice not exposed to light (dark, left) or of mice exposed to light and analyzed after 5 (5d, middle) or 10 (10d, right) d was analyzed by light microscopy. Shown are images of light-induced retinal degeneration in (A) pigmented wild-type animals, (B) pigmented Casp1–/– animals, (C) albino wild-type (BALB/c) mice, and (D) IL-1R1–/– knockout mice on an BALB/c genetic background. All mouse strains analyzed showed severe loss of photoreceptor nuclei and destruction of outer and inner segments at 5 days after exposure. At 10 days after exposure, most photoreceptor nuclei were lost. Shown are representative sections of the most affected retinal regions of two to four animals per time point and genotype. The large gap between ONL and RPE in some sections is due to a preparational artifact of the injured tissue.

 

Figure 5
View larger version (88K):
[in this window]
[in a new window]

  		FIGURE 5. Differential effect of Casp-1 gene ablation in models of inherited retinal degeneration. (A) Absence of Casp-1 in rd1 mice did not alter the progression of photoreceptor degeneration. Retinal morphology was assessed at the PNDs indicated. Casp1–/– mice had a normal retinal morphology (top). Photoreceptor degeneration proceeded similarly in rd1 and rd1/Casp–/– retinas (middle and bottom). Both showed thinning of the ONL at PND14 and almost complete loss of photoreceptors at PND21 and -37. (B) Ablation of Casp-1 delayed retinal degeneration in VPP mice. VPP and VPP/Casp1–/– double-mutant were analyzed at the PNDs indicated. Compared with VPP retinas (top), the VPP/Casp1–/– mice (bottom) showed an increased number of photoreceptor nuclei in the ONL and better preservation of photoreceptor segments. Representative sections of the most affected areas of two to four animals per time point and genotype are presented.

 
Similar to the light-damage model, we did not observe cleaved mature Casp-1 (not shown). Furthermore, in vitro cleavage assays using retinal extracts from wild-type and VPP mice at PND28 again pointed to the absence of classic Casp-1 activity (Fig 3C) .

In each of the three models of retinal degeneration, increased levels of Casp-1 coincided with the onset of photoreceptor apoptosis. Levels of Casp-1 remained high, at least until the degenerative process was completed.

Role of Casp-1 in Retinal Degeneration
Previously, we have shown that hypoxic preconditioning suppresses transcriptional upregulation of Casp-1 after exposure to light and protects photoreceptors from light-induced damage. These findings suggest that pretreatment may protect retinal morphology and function by interfering with a Casp-1-dependent pathway.29 To test the suggested role of Casp-1 in light-induced photoreceptor apoptosis, we exposed Casp1–/– and wild-type control mice, both on a mixed 129/Sv-B6 genetic background, to high levels of white light (2 hours, 13 klux) and analyzed their retinal morphology at 5 and 10 days after exposure. Absence of Casp-1 did not notably influence light-induced retinal degeneration, as progression and extent of degeneration was comparable to wild-type mice (Figs. 4A 4B) . Retinas of both genotypes, analyzed 5 days after exposure to light, were characterized by a thinned ONL and a complete disintegration of RIS and ROS. Most of the remaining photoreceptor nuclei were pyknotic, indicating ongoing cell death. Photoreceptor cells were mostly cleared from the retina 10 days after illumination. During all times, the inner retinal structures were well preserved.

As the biochemical assays used to detect mature Casp-1 and IL-1ß (Figs. 1 2) may not have been sensitive enough to detect small amounts of active proteins, we addressed a potential role of IL-1ß in retinal degeneration by using IL-1 receptor type 1 knockout mice (IL-1R1–/–) on a BALB/c background. BALB/c wild-type mice served as the control. As IL-1R1 is the only identified signaling receptor mediating the effects of IL-1ß,45 46 its absence should completely prevent any IL-1ß signaling, although the potential existence of alternative signaling mechanisms has been discussed.47 48 Wild-type and IL-1R1–/– mice were exposed to 5 klux of light for 1 hour and analyzed 5 and 10 days after exposure. Retinal degeneration was comparably severe in both types of mice (Figs. 4C 4D) .

These experiments show that lack of Casp-1 did not prevent light-induced photoreceptor degeneration and suggest that IL-1ß signaling may not be involved in the degenerative process.

Several molecular pathways exist for cell death in different forms of retinal degeneration.2 41 Therefore, we also tested the potential effect of Casp-1 ablation in the two models of inherited retinal degeneration. For this purpose, we generated rd1/Casp1–/– and VPP/Casp1–/– double-mutant mice and investigated retinal morphology at different postnatal days. Retinas of Casp1–/– mice, used as controls in this experiment, showed a normal morphologic appearance (Fig. 5A , top). Ablation of Casp-1 did not affect the course of retinal degeneration in rd1 mice, as the process proceeded without notable differences in rd1 (Fig. 5A , middle) and rd1/Casp1–/– double-mutant mice (Fig. 5A , bottom). Both rd1 and rd1/Casp1–/– retinas showed scattered apoptotic nuclei at PND11 and almost complete loss of photoreceptors by PND21.

In contrast, ablation of Casp-1 substantially protected retinal morphology in VPP mice (Fig. 5B) . At PND21, the ONL thickness in retinas of VPP mice was about half that of Casp1–/– (compare top rows of Figs. 5A and 5B ) or of wild-type mice. Most of the outer segments were severely disturbed. Accordingly, reduced levels of rhodopsin (17% compared with wild-type or Casp1–/–) were detected at this age (Table 2) . VPP/Casp1–/– double mutant mice, however, had more photoreceptor nuclei, better preserved outer segments and higher levels of rhodopsin (twice as much) than VPP mice. Preservation of retinal morphology and higher rhodopsin contents persisted until at least PND42 (Fig. 5B , Table 2 ). At PND56, the ONL was still thicker in double-mutant mice, but the structure of the outer segments was severely disturbed, which was reflected by a rhodopsin content similar to that of VPP mice. Although lack of Casp-1 protected the retina of VPP mice, morphology and rhodopsin content did not reach the quality or the amount, respectively, of wild-type or Casp1–/– animals. The continuous expression of mutant rhodopsin obviously prevented a complete protection.


View this table:
[in this window]
[in a new window]

  		TABLE 2. Rhodopsin Content in Retinas of Dark-Adapted Mice with Different Genotypes

 
Because lack of Casp-1 protected the VPP retina even though we did not observe Casp-1 cleavage activity in VPP mice in in vitro assays (Fig. 3C) , we also analyzed VPP/IL-1R1–/– double mutant animals to address a potential role IL-1ß signaling for VPP mediated retinal degeneration. Lack of IL-1R1 did not influence the degeneration in the VPP mouse retina as judged by the amount of rhodopsin at PND21 and PND42 (Table 2) and retinal morphology (not shown). This finding supports the conclusion that Casp-1 may influence retinal degeneration in the VPP mouse independent from its classic function as activator of IL-1ß signaling.

Signaling Mechanisms
To address potential signaling mechanisms involved in such a nonconventional Casp-1 function, we tested expression of several genes involved in cytokine or chemokine signaling by real-time PCR. In retinas of wild-type animals, Casp-1 gene expression remained stable and at low levels during postnatal development and aging (Fig. 6) . In VPP mice, however, increased Casp-1 gene expression was detected from PND21 (4-fold) to PND56 (10-fold), which is in line with the increased levels of Casp-1 protein detected by Western blot analysis (Fig. 3B) . The oligonucleotides used for real-time PCR hybridize upstream of the neomycin insertion (exon 6,34 ) in the Casp-1 knockout allele and can therefore detect its expression. Expression of the disrupted gene in the Casp1–/– retinas was increased compared with that in wild-type. This elevated expression was even more pronounced in the VPP/Casp1–/– mice (Fig. 6) . Obviously, lack of Casp-1 protein caused an increased transcription rate of the Casp-1 gene. This increase could be because of the lack of a negative feedback inhibition that may normally be imposed by the Casp-1 protein. The highly increased Casp-1 gene expression in the VPP/Casp1–/– retina may be an attempt to produce the protease in response to the injury (as in the VPP mouse with wild-type Casp-1). Because the protein cannot be generated, the putative regulatory feedback signal may be missing, resulting in a vicious cycle and a steady increase of gene expression.


Figure 6
View larger version (35K):
[in this window]
[in a new window]

  		FIGURE 6. Gene expression in wild-type and single- and double-mutant mice. Relative levels of indicated RNAs in retinas of wild-type, Casp1–/–, VPP, and VPP/Casp1–/– at PNDs 11, 15, 21, 28, 42, and 56, as determined by real-time RT-PCR. mRNA levels are expressed relative to those of the 11-day-old wild-type samples, which was set to 1. RNAs isolated from three independent retinas per time point and genotype were pooled, and amplifications were performed in triplicate (means ± SD).

 
Apoptosis-associated speck-like protein (asc) is a CARD (caspase recruiting domain) containing protein that is mainly involved in the activation of pro-Casp-1.49 Recently, asc has also been implicated in the activation of Casp-8.50 In contrast to the decreasing expression in wild-type mice, VPP mice show a twofold increase of asc expression with time (Fig. 6) . In mice lacking functional Casp-1, asc expression is almost undetectable (Fig. 6) suggesting that Casp-1 protein is necessary to stimulate asc gene expression. The increase of asc in VPP mice also further supports an involvement of Casp-1 in the degenerative process.

Ciliary neurotrophic factor (CNTF) and fibroblast growth factor (FGF)-2 have been implicated in retinal neuroprotection (reviewed in Ref. 41 ). Expression levels of CNTF were similar in all four strains tested (Fig. 6) . Only at PND56, both VPP and VPP/Casp1–/– showed a tendency of increased CNTF expression. Because expression increased similarly in both strains, especially at the earlier time points, CNTF may not be a factor responsible for the observed protection by ablation of Casp-1. In contrast to CNTF, expression of FGF-2 responded strongly to the presence of the VPP transgene: Expression was induced 30- to 50-fold beginning at PND21, concomitantly with the onset of the degeneration (Fig. 6) . At PND21 and PND28, expression in double-mutant mice was slightly reduced compared with that in VPP mice. This finding may reflect the reduced severity of retinal injury at this time point in these mice.

Monocyte chemoattractant protein (MCP)-1 has been implicated in the recruitment of macrophages to the site of injury.51 Because the lack of MCP-1 has been reported to cause an AMD-like phenotype in aged mice,52 MCP-1 may be needed to maintain normal retinal morphology. Whereas expression of MCP-1 was at basal levels in wild-type and Casp1–/– animals at all time points tested, its expression strongly increased in VPP (from PND21) and especially in VPP/Casp1–/– mice (from PND15; Fig. 6 ). At all time-points tested (except PND11), expression of MCP-1 was stronger in the VPP/Casp1–/– animals. Such an increased expression was not detected in Casp1–/– animals but occurred only in combination with the disease-causing transgene. Therefore, lack of Casp-1 did not result in an increased MCP-1 expression per se, suggesting that MCP-1 could be one factor, which may play a role in the protective effect of Casp-1 ablation in VPP mice.


   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
We show that Casp-1 RNA and protein are upregulated in three different models of retinal degeneration (light-induced, rd1, VPP). Our data suggest that an injured retina increases expression of the proform of Casp-1 and that this proform may exhibit a nonclassic activity different from IL-1ß cleavage. Ablation of Casp-1 slowed the disease progression only in the model with the mildest form of retinal degeneration (VPP). However, the protection observed in VPP/Casp–/– animals was only transient suggesting that additional pathways, independent of Casp-1, are involved in the regulation of retinal degeneration.

Lack of Casp-1 did not protect photoreceptors after acute light damage, in which cell death is synchronous and proceeds quickly and after which most photoreceptors are cleared from the subretinal space within 10 days. Also in the rd1 model, loss and clearance of photoreceptors occurs roughly in the same time frame, and photoreceptors are not protected by the ablation of Casp-1. In contrast, apoptosis of visual cells in the VPP mouse proceeds slowly over an extended period. In addition and contrary to light damage, cell death in the VPP mouse depends on phototransduction but not on c-Fos.33 53 Thus, significant differences in the signaling of apoptosis exist between these two models, and it appears that Casp-1 rather affects death pathways causing retinal degeneration of a milder phenotype with a slow progression. This is in line with results showing that lack of Casp-1 renders neonatal mice resistant to moderate but not to severe cerebral hypoxia-ischemia insults.54

Even though degeneration of the ONL may proceed at different speeds in the various models, the death process may nevertheless be similar on the single cell level once apoptosis is induced. Therefore, the amount of dying cells at any given time may be critical for the protective effect observed by the ablation of Casp-1. Recent theoretical and mathematical evaluations of neuronal cell death in several models of inherited retinal degeneration and other neurologic disorders suggested that a mutation imposes a mutant steady state and that a single event randomly induces cell death.55 This model has been refined by the inclusion of diffusible death factors to explain patchy cell death as it often is observed in patients with RP and in animal models.56 Such diffusible factors or at least cell-cell interactions between dying and neighboring cells have been postulated earlier57 and bystander effects were suggested to play an important role in neuronal cell death in the retina as well.58 Similarly, the magnitude of the cell death stimulus is a determining factor deciding over an acute or a chronic fate.59 Based on these reflections, we propose that lack of Casp-1 may influence a bystander effect and/or may play a role in the production, release or activity of potential death factors. The nature of the cells that may be involved in such an effect remains to be determined, but the high expression of Casp-1 in rd1 retinas at PND37 (Fig. 3A) when most photoreceptors have been cleared from the retina (Fig. 5A) suggests strong Casp-1 expression in cells different from photoreceptors. In contrast, recent reports rather convincingly demonstrate high expression of Casp-1 in the ONL in several models of retinal injury.27 28 Clearly, a careful and more elaborate study of retinal Casp-1 expression is needed to unravel the complete role of Casp-1 in disease induction and progression.

In models with almost synchronous cell death as in the light-damage model and the rd1 mouse, such effects and/or factors may be of such concentrations that lack of Casp-1 may not be able to influence their activity sufficiently. In models of slow photoreceptor degeneration, however, the reduced amount of dying cells per time may allow protection by the lack of Casp-1.

The initial analysis of factors that could be involved in the protection observed in the VPP/Casp1–/– double mutant mice revealed a striking difference in the expression of MCP-1. Expression of this chemokine is induced in the degenerating VPP retina, and lack of Casp-1 seems to stimulate its mRNA production even further (Fig. 6) . Whether MCP-1 may be involved in the protection of photoreceptors in VPP/Casp1–/– double-mutant mice remains to be shown, but it is interesting to note that lack of MCP-1 has been reported to lead to an AMD-like phenotype, including photoreceptor atrophy.52 Even though such a phenotype manifests itself only in aged animals, MCP-1 may nevertheless play a role in the survival of retinal cells, as has been suggested for central nervous system neurons,60 and/or MCP-1 may be involved in maintaining the integrity of the retinal structure.

VPP mice express a human transgene encoding a mutant rhodopsin with three amino acid substitutions (V20G, P23H, P27L), one of which (P23H) is the most prevalent mutation in patients with RP. The proposed mechanism of P23H-mediated degeneration involves formation of protein aggregations and proteasome-processing defects.61 This mechanism links this form of RP to a broad class of neurodegenerative diseases characterized by accumulation of misfolded protein aggregates such as Alzheimer disease, Parkinson disease, Huntington disease, prion encephalopathies, and amyotrophic lateral sclerosis (ALS).24 62 63 64 Casp-1-mediated pathways and -increased expression of MCP-1 have been suggested to play a role in a variety of these acute and chronic neurologic disorders,65 66 similar to the results presented herein.

It has been generally accepted that the common event for caspase activation is proteolysis of the proenzyme at internal aspartate residues producing, in the case of Casp-1, mature p20 and p10 forms. However, four lines of evidence suggests that in the retina, Casp-1 may not exhibit classic activity: First, p10 and p20 cleavage products were not detected with two different antibodies, as reported earlier by others42 ; second, we did not detect any cleavage activity in retinal extracts; third, we did not observe any mature IL-1ß, although all models showed increased Il-1ß mRNA levels; and fourth, lack of IL-1R1 did not influence retinal degeneration, suggesting that mature IL-1ß, the product of classic Casp-1 activity, is not involved in initiation and/or progression of the degeneration. Instead of mature Casp-1, we detected overaccumulation of the Casp-1 proform. Based on these data and the neuroprotective effect of Casp-1 ablation in the VPP mouse, we speculate that Casp-1 may orchestrate mechanisms of cell death independent of IL-1ß maturation. It has been reported for example that the CARD domain of the proenzyme interacts with RIP2 and activates NF{kappa}B independently of enzymatic activity.67 68 Other mechanisms are possible as well.

Recent work has revealed that initiator caspases may be activated through oligomerization and a conformational change independent of a cleavage activity.69 70 Similarly, pro-Casp-1 can be activated through oligomerization in vitro71 a process facilitated in vivo by asc.72 Overexpression of asc can lead to apoptotic cell death, and asc is silenced in human breast carcinoma and glioblastoma cells.73 74 75 In the retina of VPP mice, asc is expressed at higher levels compared with controls, whereas asc expression is almost completely silenced in mice lacking functional Casp-1 (Fig. 6) .

In summary, we showed that increased expression of Casp-1 may be a common marker for retinal degeneration, and that ablation of Casp-1 is neuroprotective, at least in a model of a comparably mild form of photoreceptor degeneration. It is important to establish the generality of these observations and to test whether interference with classic or nonclassic Casp-1 function may be an option to protect retinal cells in slowly progressing retinal degenerations.


   Acknowledgements
 
The authors thank Coni Imsand, Gaby Hoegger, and Hedwig Wariwoda for excellent technical assistance. Winnie Wong, Muna Naash, Manfred Kopf, Peter Vandenabeele and Stephen Poole generously provided mice or antibodies for this study.


   Footnotes
 
Supported by Grant 3100A0-105793 from the Swiss National Science Foundation and a grant from the European Community (EVI-GenoRet; LSHG-CT-512036) and the H. Messerli Fonds. The Laboratory of Retinal Cell Biology is a member of the Center of Integrative Human Physiology (CIHP) and of the Neuroscience Center Zürich (ZNZ) of the University of Zürich.

Submitted for publication May 19, 2006; revised August 2, 2006; accepted September 20, 2006.

Disclosure: M. Samardzija, None; A. Wenzel, None; M. Thiersch, None; R. Frigg, None; C. Remé, None; C. Grimm, None

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: Christian Grimm, Lab for Retinal Cell Biology, Department of Ophthalmology, University Hospital Zürich, Frauenklinikstrasse 24, 8091 Zürich, Switzerland; cgrimm{at}opht.unizh.ch.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;17:175–205.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  2. Pierce EA. Pathways to photoreceptor cell death in inherited retinal degenerations. Bioessays. 2001;23:605–618.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  3. Reme CE, Grimm C, Hafezi F, Marti A, Wenzel A. Apoptotic cell death in retinal degenerations. Prog Retin Eye Res. 1998;17:443–464.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  4. Chang HY, Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev. 2000;64:821–846.[Abstract/Free Full Text]
  5. Katai N, Yoshimura N. Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci. 1999;40:2697–2705.[Abstract/Free Full Text]
  6. Cascio C, Guarneri R, Russo D, et al. A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-specific caspase-2 activation in the retinal cell death. J Neurochem. 2002;83:1358–1371.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  7. Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol. 2002;132:72–82.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  8. He L, Poblenz AT, Medrano CJ, Fox DA. Lead and calcium produce rod photoreceptor cell apoptosis by opening the mitochondrial permeability transition pore. J Biol Chem. 2000;275:12175–12184.[Abstract/Free Full Text]
  9. Liu C, Li Y, Peng M, Laties AM, Wen R. Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation s334ter during photoreceptor degeneration. J Neurosci. 1999;19:4778–4785.[Abstract/Free Full Text]
  10. Yamazaki H, Ohguro H, Maeda T, et al. Preservation of retinal morphology and functions in royal college surgeons rat by nilvadipine, a Ca(2+) antagonist. Invest Ophthalmol Vis Sci. 2002;43:919–926.[Abstract/Free Full Text]
  11. Bode C, Wolfrum U. Caspase-3 inhibitor reduces apoptotic photoreceptor cell death during inherited retinal degeneration in tubby mice. Mol Vis. 2003;9:144–150.[Web of Science][Medline][Order article via Infotrieve]
  12. Hughes EH, Schlichtenbrede FC, Murphy CC, et al. Minocycline delays photoreceptor death in the rds mouse through a microglia-independent mechanism. Exp Eye Res. 2004;78:1077–1084.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  13. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature. 1990;347:677–680.[CrossRef][Medline][Order article via Infotrieve]
  14. Jomary C, Neal MJ, Jones SE. Characterization of cell death pathways in murine retinal neurodegeneration implicates cytochrome c release, caspase activation, and bid cleavage. Mol Cell Neurosci. 2001;18:335–346.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  15. Yoshizawa K, Kiuchi K, Nambu H, et al. Caspase-3 inhibitor transiently delays inherited retinal degeneration in C3H mice carrying the rd gene. Graefes Arch Clin Exp Ophthalmol. 2002;240:214–219.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  16. Sharma AK, Rohrer B. Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem. 2004;279:35564–35572.[Abstract/Free Full Text]
  17. Zeiss CJ, Neal J, Johnson EA. Caspase-3 in postnatal retinal development and degeneration. Invest Ophthalmol Vis Sci. 2004;45:964–970.[Abstract/Free Full Text]
  18. Doonan F, Donovan M, Cotter TG. Caspase-independent photoreceptor apoptosis in mouse models of retinal degeneration. J Neurosci. 2003;23:5723–5731.[Abstract/Free Full Text]
  19. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell. 1993;75:641–652.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  20. Black RA, Kronheim SR, Merriam JE, March CJ, Hopp TP. A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. J Biol Chem. 1989;264:5323–5326.[Abstract/Free Full Text]
  21. Kostura MJ, Tocci MJ, Limjuco G, et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA. 1989;86:5227–5231.[Abstract/Free Full Text]
  22. Li M, Ona VO, Guegan C, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335–339.[Abstract/Free Full Text]
  23. Li M, Ona VO, Chen M, et al. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience. 2000;99:333–342.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  24. Ona VO, Li M, Vonsattel JP, et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington’s disease. Nature. 1999;399:263–267.[CrossRef][Medline][Order article via Infotrieve]
  25. Zhang WH, Wang X, Narayanan M, et al. Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc Natl Acad Sci USA. 2003;100:16012–16017.[Abstract/Free Full Text]
  26. Grimm C, Wenzel A, Hafezi F, Reme CE. Gene expression in the mouse retina: the effect of damaging light. Mol Vis. 2000;6:252–260.[Web of Science][Medline][Order article via Infotrieve]
  27. Wu T, Chiang SK, Chau FY, Tso MO. Light-induced photoreceptor degeneration may involve the NF kappa B/caspase-1 pathway in vivo. Brain Res. 2003;967:19–26.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  28. Lohr HR, Kuntchithapautham K, Sharma AK, Rohrer B. Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death. Exp Eye Res. 2006;83:380–389.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  29. Grimm C, Wenzel A, Groszer M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med. 2002;8:718–724.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  30. Naash MI, Hollyfield JG, al-Ubaidi MR, Baehr W. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc Natl Acad Sci USA. 1993;90:5499–5503.[Abstract/Free Full Text]
  31. Goto Y, Peachey NS, Ripps H, Naash MI. Functional abnormalities in transgenic mice expressing a mutant rhodopsin gene. Invest Ophthalmol Vis Sci. 1995;36:62–71.[Abstract/Free Full Text]
  32. Naash MI, Ripps H, Li S, Goto Y, Peachey NS. Polygenic disease and retinitis pigmentosa: albinism exacerbates photoreceptor degeneration induced by the expression of a mutant opsin in transgenic mice. J Neurosci. 1996;16:7853–7858.[Abstract/Free Full Text]
  33. Samardzija M, Wenzel A, Naash M, Reme CE, Grimm C. Rpe65 as a modifier gene for inherited retinal degeneration. Eur J Neurosci. 2006;23:1028–1034.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  34. Li P, Allen H, Banerjee S, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell. 1995;80:401–411.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  35. Eriksson U, Kurrer MO, Sonderegger I, et al. Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J Exp Med. 2003;197:323–331.[Abstract/Free Full Text]
  36. Schmitz N, Kurrer M, Kopf M. The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol. 2003;33:991–1000.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  37. Hafezi F, Abegg M, Grimm C, et al. Retinal degeneration in the rd mouse in the absence of c-fos. Invest Ophthalmol Vis Sci. 1998;39:2239–2244.[Abstract/Free Full Text]
  38. Grimm C, Wenzel A, Stanescu D, et al. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci. 2004;24:5651–5658.[Abstract/Free Full Text]
  39. Wenzel A, Grimm C, Marti A, et al. c-fos controls the "private pathway" of light-induced apoptosis of retinal photoreceptors. J Neurosci. 2000;20:81–88.[Abstract/Free Full Text]
  40. Wenzel A, Oberhauser V, Pugh EN, Jr, et al. The retinal G protein-coupled receptor (RGR) enhances isomerohydrolase activity independent of light. J Biol Chem. 2005;280:29874–29884.[Abstract/Free Full Text]
  41. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005;24:275–306.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  42. Donovan M, Cotter TG. Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development. Cell Death Differ. 2002;9:1220–1231.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  43. Rich KA, Zhan Y, Blanks JC. Aberrant expression of c-Fos accompanies photoreceptor cell death in the rd mouse. J Neurobiol. 1997;32:593–612.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  44. Goto Y, Peachey NS, Ziroli NE, et al. Rod phototransduction in transgenic mice expressing a mutant opsin gene. J Opt Soc Am A Opt Image Sci Vis. 1996;13:577–585.[Web of Science][Medline][Order article via Infotrieve]
  45. Sims JE, Gayle MA, Slack JL, et al. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA. 1993;90:6155–6159.[Abstract/Free Full Text]
  46. Leon LR. Invited review: cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol. 2002;92:2648–2655.[Abstract/Free Full Text]
  47. Parker LC, Luheshi GN, Rothwell NJ, Pinteaux E. IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice. Br J Pharmacol. 2002;136:312–320.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  48. Touzani O, Boutin H, LeFeuvre R, et al. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci. 2002;22:38–43.[Abstract/Free Full Text]
  49. Mariathasan S, Newton K, Monack DM, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 2004;430:213–218.[CrossRef][Medline][Order article via Infotrieve]
  50. Parsons MJ, Vertino PM. Dual role of TMS1/ASC in death receptor signaling. Oncogene. 2006.Published online May 22
  51. Corrigall VM, Arastu M, Khan S, et al. Functional IL-2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synoviocytes: activation by IL-2 stimulates monocyte chemoattractant protein-1 production. J Immunol. 2001;166:4141–4147.[Abstract/Free Full Text]
  52. Ambati J, Anand A, Fernandez S, et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003;9:1390–1397.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  53. Hao W, Wenzel A, Obin MS, et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet. 2002;32:254–260.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  54. Xu H, Barks JD, Schielke GP, Silverstein FS. Attenuation of hypoxia-ischemia-induced monocyte chemoattractant protein-1 expression in brain of neonatal mice deficient in interleukin-1 converting enzyme. Brain Res Mol Brain Res. 2001;90:57–67.[Medline][Order article via Infotrieve]
  55. Clarke G, Collins RA, Leavitt BR, et al. A one-hit model of cell death in inherited neuronal degenerations. Nature. 2000;406:195–199.[CrossRef][Medline][Order article via Infotrieve]
  56. Burns J, Clarke G, Lumsden CJ. Photoreceptor death: spatiotemporal patterns arising from one-hit death kinetics and a diffusible cell death factor. Bull Math Biol. 2002;64:1117–1145.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  57. Huang PC, Gaitan AE, Hao Y, Petters RM, Wong F. Cellular interactions implicated in the mechanism of photoreceptor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc Natl Acad Sci USA. 1993;90:8484–8488.[Abstract/Free Full Text]
  58. Zhang M, Atherton SS. Apoptosis in the retina during MCMV retinitis in immunosuppressed BALB/c mice. J Clin Virol. 2002;25(suppl 2)S137–S147.[Medline][Order article via Infotrieve]
  59. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003;348:1365–1375.[Free Full Text]
  60. Eugenin EA, D’Aversa TG, Lopez L, Calderon TM, Berman JW. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem. 2003;85:1299–1311.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  61. Illing ME, Rajan RS, Bence NF, Kopito RR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem. 2002;277:34150–34160.[Abstract/Free Full Text]
  62. Friedlander RM, Brown RH, Gagliardini V, Wang J, Yuan J. Inhibition of ICE slows ALS in mice (published correction appears in Nature. 1998;392:560). Nature. 1997;388:31.[Medline][Order article via Infotrieve]
  63. Zhu SG, Sheng JG, Jones RA, et al. Increased interleukin-1beta converting enzyme expression and activity in Alzheimer disease. J Neuropathol Exp Neurol. 1999;58:582–587.[Web of Science][Medline][Order article via Infotrieve]
  64. Mogi M, Togari A, Kondo T, et al. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm. 2000;107:335–341.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  65. Henkel JS, Beers DR, Siklos L, Appel SH. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci. 2006;31:427–437.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  66. Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer’s disease. Neurobiol Aging. 2001;22:837–842.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  67. Lamkanfi M, Kalai M, Saelens X, Declercq W, Vandenabeele P. Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J Biol Chem. 2004;279:24785–24793.[Abstract/Free Full Text]
  68. Lamkanfi M, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases leave the beaten track: caspase-mediated activation of NF-kappaB. J Cell Biol. 2006;173:165–171.[Abstract/Free Full Text]
  69. Boatright KM, Renatus M, Scott FL, et al. A unified model for apical caspase activation. Mol Cell. 2003;11:529–541.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  70. Rodriguez J, Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 1999;13:3179–3184.[Abstract/Free Full Text]
  71. Yang X, Chang HY, Baltimore D. Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell. 1998;1:319–325.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  72. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem. 2002;277:21119–21122.[Abstract/Free Full Text]
  73. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, Vertino PM. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res. 2000;60:6236–6242.[Abstract/Free Full Text]
  74. Stone AR, Bobo W, Brat DJ, Devi NS, Van Meir EG, Vertino PM. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am J Pathol. 2004;165:1151–1161.[Abstract/Free Full Text]
  75. McConnell BB, Vertino PM. TMS1/ASC: the cancer connection. Apoptosis. 2004;9:5–18.[CrossRef][Web of Science][Medline][Order article via Infotrieve]



This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
M. Samardzija, N. Tanimoto, C. Kostic, S. Beck, V. Oberhauser, S. Joly, M. Thiersch, E. Fahl, Y. Arsenijevic, J. von Lintig, et al.
In conditions of limited chromophore supply rods entrap 11-cis-retinal leading to loss of cone function and cell death
Hum. Mol. Genet., April 1, 2009; 18(7): 1266 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Joly, C. Lange, M. Thiersch, M. Samardzija, and C. Grimm
Leukemia Inhibitory Factor Extends the Lifespan of Injured Photoreceptors In Vivo
J. Neurosci., December 17, 2008; 28(51): 13765 - 13774.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. A. Rao, S. Saraswathy, G. S. Wu, G. S. Katselis, E. F. Wawrousek, and S. Bhat
Elevated Retina-Specific Expression of the Small Heat Shock Protein, {alpha}A-crystallin, Is Associated with Photoreceptor Protection in Experimental Uveitis
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1161 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Samardzija, J. von Lintig, N. Tanimoto, V. Oberhauser, M. Thiersch, C. E. Reme, M. Seeliger, C. Grimm, and A. Wenzel
R91W mutation in Rpe65 leads to milder early-onset retinal dystrophy due to the generation of low levels of 11-cis-retinal
Hum. Mol. Genet., January 15, 2008; 17(2): 281 - 292.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Samardzija, M.
Right arrow Articles by Grimm, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Samardzija, M.
Right arrow Articles by Grimm, C.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS